Severity of obstructive airway disease and risk of osteoporotic fracture

de Vries F., van Staa T. P., Bracke M. S. G. M., Cooper C., Leufkens H. G. M., Lammers J-W. J.

Source: Eur Respir J 2005; 25: 879-884
Journal Issue: May
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
de Vries F., van Staa T. P., Bracke M. S. G. M., Cooper C., Leufkens H. G. M., Lammers J-W. J.. Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 2005; 25: 879-884

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High prevalence of vertebral deformities in COPD patients: relationship to disease severity
Source: Eur Respir J 2009; 33: 1018-1024
Year: 2009



FRAX program as a method of assessing the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012


The absolute risk of osteoporotic fractures according to the program of FRAX patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012


Osteoporosis in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 64S-75S
Year: 2003



Non-traumatic vertebral fractures among COPD patients
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018



Vertebral deformity and hyperkyphosis in people with chronic obstructive pulmonary disease
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016

The decrease of nutritional status and increasing of the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler(R)
Source: Eur Respir J 2002; 19: 1058-1063
Year: 2002



Disease severity of asthma/COPD and risk of osteoporotic fractures
Source: Eur Respir J 2004; 24: Suppl. 48, 431s
Year: 2004

Osteoporosis, vertebral fracture and bone metabolism in COPD patients
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008



The effect of statin therapy in patients with chronic obstructive airway disease
Source: International Congress 2015 – COPD: notable points
Year: 2015


COPD and osteoporosis
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014

Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids
Source: Annual Congress 2006 - COPD therapy
Year: 2006


High prevalence of vertebral deformities in COPD patients is not related only to systemic steroid use
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008

Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Secondary prevention of osteoporosis (OP) in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015


Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


The effects of inhaled corticosteroids on risk of self-reported osteoporosis and fractures in adult subjects with asthma
Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS
Year: 2017


N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 795-798
Year: 2003